CD155/PVR plays a key role in cell motility during tumor cell invasion and migration

BMC Cancer

Volumn 4, Issue , 2004, Pages

  Sloan, Kevin E ^a   Eustace, Brenda K ^a   Stewart, Jean K ^a   Zehetmeier, Carol ^b   Torella, Claudia ^b   Simeone, Marina ^a   Roy, Jennifer E ^c   Unger, Christine ^b   Louis, David N ^c   Ilag, Leodevico L ^b   Jay, Daniel G ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Xerion Pharmaceuticals AG   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CD51 ANTIGEN; CHEMOATTRACTANT; MATRIGEL; MEMBRANE PROTEIN; VIRUS RECEPTOR; VITRONECTIN RECEPTOR; POLIOVIRUS RECEPTOR; TUMOR PROTEIN;

ANTIBODY LIBRARY; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL SHAPE; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; FIBROSARCOMA; FUNCTIONAL PROTEOMICS; GLIOBLASTOMA; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; METASTASIS; MULTIPLE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA INTERFERENCE; TUMOR CELL; CELL MOTION; IMMUNOPRECIPITATION; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; PROTEOMICS; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; FIBROSARCOMA; GLIOBLASTOMA; HUMANS; IMMUNOPRECIPITATION; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEOMICS; RECEPTORS, VIRUS;

EID: 13144299338     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-4-73     Document Type: Article

References (41)

1. Sporn MB: The war on cancer. Lancet 1996, 347: 377.
2. Bogenrieder T, Herlyn M: Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 2003, 22:6524.
3. Louis DN, Posner JB, Jacobs T, Kaplan R: Report of the Brain Tumor Progress Review Group. 2000 [http://http:prg.nci.nih.gov/brain/finalport.html].
4. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR: Cell migration: integrating signals from front to back. Science 2003, 302:1704.
5. Hsu MY, Meier F, Herlyn M: Melanoma development and progression: a conspiracy between tumor and host. Differentiation 2002, 70:522.
6. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V: Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000, 406:536.
7. Clark EA, Golub TR, Lander ES, Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000, 406:532.
8. MacDonald TJ, Brown KM, LaFleur B, Peterson K, Lawlor C, Chen Y, Packer RJ, Cogen P, Stephan DA: Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 2001, 29:143.
9. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Willaims C, Zhu SX, Lonning PE, Borressen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature 2000, 406:747.
10. Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 2003, 33:49.
11. Aza-Blanc P, Cooper CL, Wagner K, Batalov S, Deveraux QL, Cooke MP: Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol Cell 2003, 12:627.
12. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, Agami R, Ge W, Cavet G, Linsley PS, Beijersbergen RL, Bernards R: A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004,428:431.
13. Hauptschein RS, Eustace BK, Jay DG: Global high-throughput screens for cellular function. Exp Hematol 2002, 30:381.
14. Beck S, Sakurai T, Eustace BK, Beste G, Schier R, Rudert F, Jay DG: Fluorophore- assisted light inactivation: a high-throughput tool for direct target validation of proteins. Proteomics 2002, 2:247.
15. Eustace BK, Jay DG: Fluorophore-assisted light inactivation for multiplex analysis of protein function in cellular processes. Methods Enzymol 2003, 360:649.
16. Eustace BK, Sakurai T, Stewart JK, Yimlamai D, Unger C, Zehetmeier C, Lain B, Torella C, Henning SW, Beste G, Scroggins BT, Neckers L, Hag LL, Jay DG: Functional proteomic screens reveal an essential extracellular role for hsp90alpha in cancer cell invasiveness. Nat CellBiol 2004, 6:507.
17. Haugland RP: Coupling of monoclonal antibodies with fluorophores. Methods Mol Biol 1995, 45:205.
18. Hood JD, Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer 2002, 2:91.
19. Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E: Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci USA 2000,97:6803.
20. Marshall JF, Hart IR: The role of alpha v-integrins in tumour progression and metastasis. Semin Cancer Biol 1996, 7: 29.
21. Gross ME, Shazer RL, Agus DB: Targeting the HER-kinase axis in cancer. Semin Oncol 2004, 31:9.
22. Mendelsohn CL, Wimmer E, Racaniello VR: Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989, 56:855.
23. Mueller S, Wimmer E: Recruitment of nectin-3 to cell-cell junctions through trans-heterophilic interaction with CD155, a vitronectin and poliovirus receptor that localizes to alpha(v)beta3 integrin-containing membrane microdomains. J Biol Chem 2003, 278:31251.
24. Takai Y, Irie K, Shimizu K, Sakisaka T, Ikeda W: Nectins and nectin-like molecules: roles in cell adhesion, migration, and polarization. Cancer Sci 2003, 94:655.
25. Takai Y, Nakanishi H: Nectin and afadin: novel organizers of intercellular junctions. J Cell Sci 2003, 116:17.
26. Lange R, Peng X, Wimmer E, Lipp M, Bernhardt G: The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin. Virology 2001, 285: 18.
27. Boudreau NJ, Jones PL: Extracellular matrix and integrin signalling: the shape of things to come. Biochem J 1999, 339: 81.
28. Owen JD, Ruest PJ, Fry DW, Hanks SK: Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion- dependent tyrosine phosphorylation of Pyk2. Mol Cell Biol 1999, 19:4806.
29. Brown EJ, Frazier WA: Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 2001, 11:130.
30. Brittain JE, Han J, Ataga KI, Orringer EP, Parise LV: Mechanism of CD47-induced alpha 4beta 1 integrin activation and adhesion in sickle reticulocytes. J Biol Chem 2004, 279(): 2393-42402.
31. Mueller S, Cao X, Welker R, Wimmer E: Interaction of the poliovirus receptor CD155 with the dynein light chain Tctex-1 and its implication for poliovirus pathogenesis. J Biol Chem 2002, 277:7897.
32. Freistadt MS, Eberle KE: Physical association between CD155 and CD44 in human monocytes. Mol Immunol 1997, 34: 247.
33. Jin H, Varner J: Integrins: roles in cancer development and as treatment targets. Br J Cancer 2004, 90:561.
34. Oda T, Ohka S, Nomoto A: Ligand stimulation of CD155alpha inhibits cell adhesion and enhances cell migration in fibroblasts. Biochem Biophys Res Commun 2004, 319:1253.
35. Gromeier M, Solecki D, Patel DD, Wimmer E: Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: implications for the pathogenesis of poliomyelitis. Virology 2000, 273:248.
36. Ida-Hosonuma M, Sasaki Y, Toyoda H, Nomoto A, Gotoh O, Yonekawa H, Koike S: Host range of poliovirus is restricted to simians because of a rapid sequence change of the poliovirus receptor gene during evolution. Arch Virol 2003, 148:29.
37. Ikeda W, Kakunaga S, Takekuni K, Shingai T, Satoh K, Morimoto K, Takeuchi M, Imai T, Takai Y: Nectin-like molecule-5/Tage4 enhances cell migration in an integrin-dependent, Nectin-3-independent manner. J Biol Chem 2004, 279:18015.
38. Ravens I, Seth S, Forster R, Bernhardt G: Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155. Biochem Biophys Res Commun 2003, 312:1364.
39. Bernhardt G, Bibb JA, Bradley J, Wimmer E: Molecular characterization of the cellular receptor for poliovirus. Virology 1994, 199:105.
40. Masson D, Jarry A, Baury B, Blanchardie P, Laboisse C, Lustenberger P, Denis MG: Overexpression of the CD155 gene in human colorectal carcinoma. Gut 2001, 49:236.
41. Ochiai H, Moore SA, Archer GE, Okamura T, Chewning TA, Marks JR, Sampson JH, Gromeier M: Treatment of intracerebral neoplasia and neoplastic meningitis with regional delivery of oncolytic recombinant poliovirus. Clin Cancer Res 2004, 10:4831.